Area of research
Nephrology · Hematology
Research interest
Research interests include Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Parathyroid Disorders and Treatments, and Erythropoietin and Anemia Treatment.
Diagnosis, management and treatment of the Alport syndrome – 2024 guideline on behalf of ERKNet, ERA and ESPN
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies
Burden of CKD-Associated Pruritus and Adverse Clinical Outcomes in Patients Receiving Dialysis: The Stockholm Creatinine Measurements (SCREAM) Project
Discordances Between Creatinine- and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations
Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care
Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
Pediatric transplantation in Europe during the COVID‐19 pandemic: Early impact on activity and healthcare
Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study
Reduced skeletal muscle expression of mitochondrial-derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
Estimated Glomerular Filtration Rate and the Risk of Cancer
Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease
Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
Incidence, Predictors and Clinical Management of Hyperkalaemia in New Users of Mineralocorticoid Receptor Antagonists
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project
Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction
eGFR and the Risk of Community-Acquired Infections